Becton Dickinsonvs.Boston Scientific
BDX vs BSX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 1.6× larger than Becton Dickinson by market cap; Boston Scientific trades at the lower P/E (18.7 vs 36.8); year to date, Becton Dickinson leads (−0.4% vs −53.0%).
Side by side
| BDX | BSX | |
|---|---|---|
| Market cap | $41.9B | $66.5B |
| Price | $151.94 | $44.77 |
| Today | +0.7% | −0.5% |
| Return YTD | −0.4% | −53.0% |
| Return 1Y | +8.9% | −56.9% |
| P/E | 36.8 | 18.7 |
| P/S | 2.0 | 3.2 |
| P/B | 1.7 | 2.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
American medtech group with a broad portfolio of medical consumables, diagnostics and drug delivery (syringes, needles).
Full BDX profile →Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →More comparisons in Medtech & devices
See where BDX and BSX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →